Difference between revisions of "Team:WLC-Milwaukee"
m (deleted template stuff) |
m (deleted template stuff) |
||
| Line 4: | Line 4: | ||
<div class="highlightBox"> | <div class="highlightBox"> | ||
| + | |||
| + | <br /> | ||
| + | <br /> | ||
| + | <br /> | ||
| + | <br /> | ||
<h4> Project Description</h4> | <h4> Project Description</h4> | ||
<p>For this year's project the WLC-Milwaukee team is looking into phage therapy. Specifically we are looking for phages specific to the outer-membrane efflux pore protein tolC. tolC analogs are found in most gram-negative bacteria, and they have been implicated as an essential protein in an efflux-based resistance mechanism to certain types of antibiotics. Our project involves expressing tolC homologs from infectious strains of bacteria in a tolC knockout strain of E coli. We are using these transgenic E coli to search for bacteriophages specific to our selected gastrointestinal tract pathogen's versions of tolC. Our hope is that the phages specific for a pathogen's tolC can be used in combination with an antibiotic generally resisted via an efflux mechanism to put the pathogenic bacteria in a lose-lose dilemma: bacteria which try to efflux the antibiotics will expose themselves to the pathogen-specific phage, while those which do not express TolC will be weakened to the antibiotic therapy. </p> | <p>For this year's project the WLC-Milwaukee team is looking into phage therapy. Specifically we are looking for phages specific to the outer-membrane efflux pore protein tolC. tolC analogs are found in most gram-negative bacteria, and they have been implicated as an essential protein in an efflux-based resistance mechanism to certain types of antibiotics. Our project involves expressing tolC homologs from infectious strains of bacteria in a tolC knockout strain of E coli. We are using these transgenic E coli to search for bacteriophages specific to our selected gastrointestinal tract pathogen's versions of tolC. Our hope is that the phages specific for a pathogen's tolC can be used in combination with an antibiotic generally resisted via an efflux mechanism to put the pathogenic bacteria in a lose-lose dilemma: bacteria which try to efflux the antibiotics will expose themselves to the pathogen-specific phage, while those which do not express TolC will be weakened to the antibiotic therapy. </p> | ||
Revision as of 02:38, 21 August 2015
|
Project Description
For this year's project the WLC-Milwaukee team is looking into phage therapy. Specifically we are looking for phages specific to the outer-membrane efflux pore protein tolC. tolC analogs are found in most gram-negative bacteria, and they have been implicated as an essential protein in an efflux-based resistance mechanism to certain types of antibiotics. Our project involves expressing tolC homologs from infectious strains of bacteria in a tolC knockout strain of E coli. We are using these transgenic E coli to search for bacteriophages specific to our selected gastrointestinal tract pathogen's versions of tolC. Our hope is that the phages specific for a pathogen's tolC can be used in combination with an antibiotic generally resisted via an efflux mechanism to put the pathogenic bacteria in a lose-lose dilemma: bacteria which try to efflux the antibiotics will expose themselves to the pathogen-specific phage, while those which do not express TolC will be weakened to the antibiotic therapy.